aluminum phosphide has been researched along with triiodothyronine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdolghaffari, AH; Abdollahi, M; Baeeri, M; Baghaei, A; Dehpour, AR; Gooshe, M; Hassani, S; Jafari, A; Mehr, SE; Navaei-Nigjeh, M; Rezayat, SM; Solgi, R | 1 |
| Abdollahi, M; Arefi, M; Baeeri, M; Goharbari, MH; Mojtahedzadeh, M; Nikfar, S; Rahimifard, M; Sharifzadeh, M; Taghaddosinejad, F | 1 |
1 trial(s) available for aluminum phosphide and triiodothyronine
| Article | Year |
|---|---|
Therapeutic effects of oral liothyronine on aluminum phosphide poisoning as an adjuvant therapy: A clinical trial.
Topics: Administration, Oral; Adult; Aluminum Compounds; Antidotes; Biomarkers; Blood Pressure; Cardiovascular Diseases; Female; Humans; Hydrogen-Ion Concentration; Iran; Lipid Peroxidation; Male; Oxidative Stress; Pesticides; Phosphines; Time Factors; Treatment Outcome; Triiodothyronine | 2018 |
1 other study(ies) available for aluminum phosphide and triiodothyronine
| Article | Year |
|---|---|
Molecular and biochemical evidences on the protective effects of triiodothyronine against phosphine-induced cardiac and mitochondrial toxicity.
Topics: Aluminum Compounds; Animals; Apoptosis; Blood Pressure; Cardiotonic Agents; Electrocardiography; Heart; Heart Rate; Male; Mitochondria, Heart; Oxidative Stress; Pesticides; Phosphines; Rats, Wistar; Triiodothyronine | 2015 |